Loading clinical trials...
Loading clinical trials...
Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System
Conditions
Interventions
Gablofen® 3 mg/mL (baclofen injection)
SynchroMed® II Programmable Pump
Locations
13
United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Loma Linda University
Loma Linda, California, United States
Rehabilitation Medicine Department, University of Miami, Miller School of Medicine
Miami, Florida, United States
Rehabilitation Institute of Chicago
Chicago, Illinois, United States
Wayne State University, School of Medicine
Dearborn, Michigan, United States
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota, United States
Start Date
December 1, 2012
Primary Completion Date
August 1, 2016
Completion Date
October 1, 2016
Last Updated
May 3, 2019
Lead Sponsor
Piramal Critical Care, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions